SMTL ID : 5mgi.1

Crystal structure of KPC-2 carbapenemase in complex with a phenyl boronic inhibitor.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x 6YV: (~{E})-3-[2-(dihydroxyboranyl)phenyl]prop-2-enoic acid(Covalent)

6YV.1: 14 residues within 4Å: Chain A: C.43, S.44, K.47, W.79, S.104, N.106, E.140, L.141, N.144, R.194, K.208, T.209, G.210, T.211 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.79, A:L.141 Hydrogen bonds: A:S.44, A:S.104, A:S.104, A:N.144, A:N.144, A:T.211, A:T.211, A:T.211 Water bridges: A:T.209, A:T.209 Salt bridges: A:R.194, A:K.208

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Celenza, G. et al., Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance. Chemmedchem (2018)

Release Date

2018-03-14

Peptides

Carbapenem-hydrolyzing beta-lactamase KPC: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Carbapenem-hydrolyzing beta-lactamase KPC

Related Entries With Identical Sequence